*Purpose: Simultaneous liver-kidney transplant (SLK) has become an increasingly popular option due to commonly comorbid renal insufficiency in liver failure,. Following SLK, it is unknown whether improvement in renal function is due to function of the transplant kidney, return of function of the native kidneys, or both. We sought to determine the return of native renal function following SLK and investigate predictive factors.

*Methods: Following SLK, patients underwent Mag-3 scan following their serum creatinine nadir as part of a quality initiative, and review of the cohort was IRB-approved. Relative contribution of each kidney was calculated based on Mag-3 and eGFR. Patients with good return of native renal function (native contribution eGFR≥30) were compared to those with poor return of native renal function (native contribution eGFR<30) using descriptive statistical analysis, and a final logistic regression model and ROC curve were generated.

*Results: 31 of 34 patients who underwent SLK from August 2019 to May 2021 at our institution were included in analysis. 3 patients had no Mag-3 performed due to scheduling/logistical issues. At baseline, 42% of patients had ESRD, 29% had CKD4/5, and 29% had CKD3. Following SLK, average native-only kidney contribution to overall renal function was 51.1%, corresponding to average native-only eGFR 44.5 (SD 15.2). The transplant kidney’s contribution to overall renal function was 49.0%. 26 of 31 (83.9%) patients had native kidney-only contribution of eGFR of 30 (CKD3) or better. Hepatorenal syndrome, without other original disease was a significant predictor of good return of native renal function (OR 32.0, 95% CI: 1.56 – 656, p=0.025). The final model, which also included preoperative CKD4 or better, was accurate with 93.5% of the cases predicted correctly (p=0.0003). The associated area under the ROC curve was 0.95 (CI: 0.86 – 1.0, Figure).

*Conclusions: Simultaneous liver-kidney transplantation was frequently accompanied by return of native renal function. Hepatorenal syndrome without other original disease was a predictor of good return of native renal function. Randomized trials are needed to determine which patients would be best suited for SLK versus liver transplant alone, with the later option for subsequent kidney transplant via the safety net mechanism.

« Back to 2022 American Transplant Congress